Adoption of Lutetium-(177) PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020
德国2016年至2020年采用镥-(177)PSMA放射性配体疗法治疗转移性去势抵抗性前列腺癌:一项全人群分析
期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-023-06139-x
Flegar, Luka; Thoduka, Smita George; Librizzi, Damiano; Luster, Markus; Zacharis, Aristeidis; Heers, Hendrik; Eisenmenger, Nicole; Ahmadzadehfar, Hojjat; Eiber, Matthias; Weber, Wolfgang; Groeben, Christer; Huber, Johannes